Tag Archives: RESI

Get Ready, RESI Partnering Opens Monday, August 21st – New Premier Partnering Plus Is On The Docket

17 Aug

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-new

On Monday August 21st, Partnering for RESI Boston will open and all the entrepreneurs and investors attending the event will be able to start filling out their dance cards for RESI’s one-on-one meetings.  While RESI Partnering has always been the heart of the event, RESI also offers dozens of educational panels and workshops and also an engaging venue for ad-hoc networking.

The new Premier Partnering Plus will feature deep profiles of investors and strategic players that can be used to ensure attending startups get in front of the most relevant, best-fit buy side players possible.  Below is a partial list of investors who are already signed up to take part.  These investors range from family offices to major pharma players, from local funds to international cross border investors. Entrepreneurs can meet an incredible diversity of global investors at RESI Boston and continue the dialogue 6 weeks later at RESI NYC November 15.

While all attendees can use RESI Partnering to send meeting requests to attending investors, Premier Partnering Plus registrants will have a new unique tool to vet investor fits through viewing full mandate data for each investor.  This additional service will inform entrepreneurs as to what kind of opportunities these investors are most focused on, and for the first time, will also provide entrepreneurs with access to direct contact info.  In a previous edition, we took a closer look at what Premier Partnering Plus adds to the RESI experience.  If you’re already registered and would like to talk about upgrading your registration, please contact us at resi@lifesciencenation.com.

CONFIRMED INVESTORS AND STRATEGIC PARTNERS

Tags: , ,

Need Seed Stage Device Capital? Meet the Medtech Angels at RESI Boston

17 Aug

By James Huang, Research Analyst, LSN

james-wp

With medical technology entrepreneurs facing a challenging capital landscape, angel capital remains a vital source of early stage funding in the sector.  According to studies by the Angel Resource Institute, of every angel dollar invested in the USA, nearly 20 cents goes into healthcare and life sciences.  In recognition of the importance of angel financing to early stage companies, RESI features two angel panels, and today we would like to announce our Medtech Angels panel for RESI Boston.  If you’re interested in how to pitch to an angel group, what makes a medtech opportunity suitable for angel investment, or how angels work with their portfolio companies to hit subsequent milestones and follow-on raises, this panel is for you.

LSN has brought together five highly experienced angels who have a focus on medical technology investment.  The participants are:

Tags: , , , ,

WuXi AppTec Signs on as a RESI Title Sponsor for Boston, NYC and San Francisco Conferences

10 Aug

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-newLSN is pleased to announce WuXi AppTec will be a title sponsor to the RESI Conference Series in our upcoming Boston, NYC and San Francisco conferences. WuXi AppTec is a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform. WuXi AppTec joins RESI as a title sponsor along with JLABS, which currently has eight locations in innovation hotspots across North America and produces entrepreneurial programs and campaigns to seek out the best science. This pair of global early stage players will add another conduit to the early stage companies that come to RESI to find investor capital and strategic partnerships as they move forward in their product cycles.

The WuXi AppTec-LSN relationship has been growing over the years and WuXi AppTec has helped and been a contributor in our efforts with RESI content programing, panel participation, and creation of relationships with the scientist entrepreneurs and fundraising CEOs who are the main constituents of the RESI conference series.

Tags: , , , , ,

Apply by Tomorrow (August 11th) to Win Your Spot in the RESI Boston Innovation Challenge

10 Aug

By Chris Cummings, Senior Business Development Manager, LSN

With just over seven weeks to go RESI Boston, LSN is getting ready to assess which health innovators will be awarded a display spot in our NIH-sponsored RESI Innovation Challenge.  If you would like to participate and get an exhibit hall display spot to market your company to life science investors, it’s not too late to apply.

The RESI Innovation Challenge covers startups in therapeutics, medtech, diagnostics and healthcare IT companies from around the globe. All applicants will be vetted based on not only the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.

On September 26th, RESI’s estimated 1000 attendees will receive “RESI Cash” to allocate to the entrepreneurs whose technologies they expect will be most influential. The capital invested will be tallied up and the top three winners will receive prizes and be featured in our RESI newsletter recap that will go out to LSN’s 20,000 newsletter readership. See below for the previous RESI Innovation Challenge first place winners – a diverse group of startups from every area of the life sciences.

Michael Quigley, VP of Market Research, Life Science Nation | Mo Chen, Co-Founder & Chief Science Officer, Taithera | Seth Harlem, Co-Founder & Chief Executive Officer, Taithera

See below for the previous RESI Innovation Challenge testimonials.

“RESI Innovation Challenge was a fantastic way for us to increase exposure to investors attending the event. We highly recommend leveraging the Innovation Challenge with the one-on-one partnering platform to get more face time with investors.”

– Herman Lo, CEO, ViewsIQ Inc.

3rd Place in San Diego IC

DSC00392

“It was an absolute pleasure to participate in the RESI conference held at MaRS in Toronto. The unique structure of the conference facilitated creating new relationships with potential investors and partners. In particular, the Innovation Challenge pushed us to introduce ourselves to new people, which will be useful as we look towards a future financing round. I definitely recommend the RESI conferences to entrepreneurs seeking financing in the bio / health space.”

– Raymond Shih, President, Co-Founder, QoC Health

3rd Place, RESI on MaRS, June 23, 2016

02

“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015

Tags: ,

RESI San Diego: Family Office Investors Discuss Strategy and What Makes Them Different

20 Jul

By Cole Bunn, Senior Research Analyst, LSN

cole-wp

As the RESI San Diego event is now in the rearview mirror and we prepare to bring RESI home to Boston (Sept. 26th), we wanted to take a closer look at the Medtech Family Office panel session. Family offices are clearly a highly sought-after investor class and are not completely understood by a large portion of entrepreneurs. To that end, we’ve pulled out some of the most insightful points that were discussed and distilled the panel session into this summary video to help shed some light on how family offices evaluate early-stage investments, how to reach them and what differentiates them from VCs and other early-stage investors.

Family offices are not a silver bullet for your financing needs

A lot of entrepreneurs mistakenly believe that finding a family office will solve all their fundraising woes i.e. long-term investors with less rigid requirements. While it is true that family offices tend to be more patient capital and more flexible with terms and deal structures (a result of not having to answer to LPs), these groups are in fact looking for a return and typically will be active either at the board or management level to hit milestones and create value. Additionally, as your company grows and matures, the capital requirements and expertise required for the healthcare space oftentimes necessitate bringing in deep-pocketed institutional investors, who family offices maintain relationships with.

Family offices are purposefully low visibility

Given that family office investors have no mandate or timeline to allocate money, they can wait on the best deals and entrepreneurs to surface, therefore their deal sourcing channels are much different than a VC or another institutional investor. Further, these groups tend to be very much relationship-oriented. Networking is a must to uncover these investors and begin building a relationship, with some of the best events to attend being a part of universities and tech transfer offices as well as focused partnering conferences, such as the RESI conference.

Family offices are not homogenous

This point can’t be stressed enough. While there are some common themes among these groups (mostly dictated by structure or lack thereof), they are largely very different. Some may be more philanthropically motivated as they are looking to fund research/companies pursuing indications that have afflicted their family while others act more like an institutional fund with a focus on returns. It is essential to do as much research as possible on each specific family office to try and find mutual connections and the best way to approach them.

Moderated by Michael Quigley, VP of Investor Research, LSN, the panel includes the following speakers:

  • Sean Kearny, Managing Director, Three Leaf Ventures
  • Kyle Williams, President, Bootstrap Incubation
  • John Kinzell, Sr. Life Science Analyst, The McNair Group
  • Julia Belaya, Director – Corporate Partnerships, Plug & Play Tech Center

Tags: , , , , , ,

RESI Premier Partnering Plus – An In Depth Look At RESI’s New Enhanced Partnering Service

13 Jul

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-new

In last week’s Next Phase newsletter, LSN announced the new Premier Partnering Plus service for RESI attendees.  This week, we’d like to give you a more in depth look at how Premier Partnering Plus will take RESI Partnering to the next level, and show you an example of the extra information that will be available to attendees who opt for the Premier Partnering Plus pass.  RESI Early Bird rates end on Friday, so now is the time to sign up.

Premier Partnering Plus users will receive:

  • Detailed investment and deal mandate information to help dial in who they need to meet with based on fit
  • Include specifics on the sectors and subsectors
  • Indication interest, company and management team requirements
  • Contact information and best way to reach out to an investor

Below, you can take a look at an example of what Premier Partnering Plus attendees will be able to see once RESI Partnering launches.

This a first for integrating a world class investor & strategic data platform with a partnering application, and will make attendees who use the service much more selective, efficient and successful in their partnering activities.

(Click to watch LSN Investor Platform intro video)

Tags: , ,

Calling All Life Science Entrepreneurs – Enter the RESI Boston Innovation Challenge

13 Jul

By Chris Cummings, Senior Business Development Manager, LSN

Christine A. Wu, Senior Research Analyst, LSN

chrsitineRESI is coming home to Boston and so is the RESI Innovation Challenge. This September’s life science innovation competition will showcase the most promising new health technologies in the RESI Innovation Challenge. If you are fundraising and aim to build a presence in the Boston’s booming healthcare scene, we’d like to see your application.

The RESI Innovation Challenge invites the top-tier early-stage companies in therapeutics, medical devices, diagnostics and healthcare IT to present from around the globe. All applicants will be vetted on the crucial balance of the quality of the company’s scientific innovation and the investment potential based on the company current standings and management team.

On September 26th, RESI’s estimated 1000 attendees will receive “RESI Cash” to “invest” in the company whom they believe to be the most “investible” of the contestants. The top three winners with the most RESI cash will receive prizes and be featured in our RESI newsletter recap that will go out to LSN’s 20,000 newsletter readership.

In the past we have seen around 50% of Innovation Challenge companies receive funding within a year from their exhibition at RESI. Be sure not to miss out on the chance of adding to this statistic – apply for the Innovation Challenge.

See below for the previous RESI Innovation Challenge testimonials.

“RESI Innovation Challenge was a fantastic way for us to increase exposure to investors attending the event. We highly recommend leveraging the Innovation Challenge with the one-on-one partnering platform to get more face time with investors.”

– Herman Lo, CEO, ViewsIQ Inc.

3rd Place in San Diego IC

DSC00392

“It was an absolute pleasure to participate in the RESI conference held at MaRS in Toronto. The unique structure of the conference facilitated creating new relationships with potential investors and partners. In particular, the Innovation Challenge pushed us to introduce ourselves to new people, which will be useful as we look towards a future financing round. I definitely recommend the RESI conferences to entrepreneurs seeking financing in the bio / health space.”
– Raymond Shih, President, Co-Founder, QoC Health
3rd Place, RESI on MaRS, June 23, 2016

02

“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015

Tags: , , , ,

← Older Entries
Newer Entries →